Published in Biochem Biophys Res Commun on April 30, 2007
Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach. BMC Genomics (2009) 0.83
Preclinical and Clinical Studies for Sodium Tungstate: Application in Humans. J Clin Cell Immunol (2015) 0.79
Anti-obesity sodium tungstate treatment triggers axonal and glial plasticity in hypothalamic feeding centers. PLoS One (2012) 0.77
Human placental lactogen (hPL-A) activates signaling pathways linked to cell survival and improves insulin secretion in human pancreatic islets. Islets (2011) 0.76
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet (2002) 9.48
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet (2009) 8.54
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA (2003) 8.47
Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care (2005) 3.55
Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci (2007) 2.89
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J (2010) 2.68
Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance. Cell (2013) 2.43
Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes. Diabetes Care (2004) 1.75
Identification of a pancreatic stellate cell population with properties of progenitor cells: new role for stellate cells in the pancreas. Biochem J (2009) 1.64
GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg (2006) 1.60
Histone demethylase LSD1 regulates adipogenesis. J Biol Chem (2010) 1.50
[Organization and functioning model of biomedical research structures. Situation and future challenges]. Med Clin (Barc) (2008) 1.46
Liver glycogen synthase but not the muscle isoform differentiates between glucose 6-phosphate produced by glucokinase or hexokinase. J Biol Chem (2002) 1.45
Control of glycogen deposition. FEBS Lett (2003) 1.43
Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease. EMBO Mol Med (2011) 1.24
Insulin-dependent diabetes affects testicular function by FSH- and LH-linked mechanisms. J Androl (2004) 1.24
Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem (2006) 1.21
Crystal structure of an archaeal glycogen synthase: insights into oligomerization and substrate binding of eukaryotic glycogen synthases. J Biol Chem (2005) 1.12
Induction of pancreatic islet cell differentiation by the neurogenin-neuroD cascade. Differentiation (2007) 1.09
Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res (2004) 1.06
Hypothalamic and brainstem neuronal circuits controlling homeostatic energy balance. J Endocrinol (2014) 1.05
Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg (2008) 1.04
Control of liver glycogen synthase activity and intracellular distribution by phosphorylation. J Biol Chem (2009) 1.04
Dynamic profiling of the glucose metabolic network in fasted rat hepatocytes using [1,2-13C2]glucose. Biochem J (2004) 1.03
Chromatin and chromatin-modifying proteins in adipogenesis. Biochem Cell Biol (2007) 1.02
Identification of the bHLH factor Math6 as a novel component of the embryonic pancreas transcriptional network. PLoS One (2008) 1.00
Impairment in long-term memory formation and learning-dependent synaptic plasticity in mice lacking glycogen synthase in the brain. J Cereb Blood Flow Metab (2013) 0.99
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study). Cardiovasc Diabetol (2008) 0.99
Deletion of miRNA processing enzyme Dicer in POMC-expressing cells leads to pituitary dysfunction, neurodegeneration and development of obesity. Mol Metab (2012) 0.98
Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual β-cells. Endocrinology (2013) 0.97
Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care (2007) 0.97
Involvement of the clock gene Rev-erb alpha in the regulation of glucagon secretion in pancreatic alpha-cells. PLoS One (2013) 0.97
Glycogen synthase: towards a minimum catalytic unit? FEBS Lett (2002) 0.96
Alternative splicing of the human proto-oncogene c-H-ras renders a new Ras family protein that trafficks to cytoplasm and nucleus. Cancer Res (2003) 0.95
Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model. J Immunol (2008) 0.94
AMP-activated protein kinase phosphorylates and inactivates liver glycogen synthase. Biochem J (2012) 0.94
Development and functional characterization of insulin-releasing human pancreatic beta cell lines produced by electrofusion. J Biol Chem (2011) 0.93
Deleterious effects of neuronal accumulation of glycogen in flies and mice. EMBO Mol Med (2012) 0.93
Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action. PLoS One (2007) 0.92
A chromatin perspective of adipogenesis. Organogenesis (2010) 0.92
Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies. Diabetes Res Clin Pract (2007) 0.90
Determinants of the nucleocytoplasmic shuttling of muscle glycogen synthase. FEBS J (2005) 0.90
Glucose 6-phosphate produced by gluconeogenesis and by glucokinase is equally effective in activating hepatic glycogen synthase. J Biol Chem (2003) 0.89
Utilization of citrate and lactate through a lactate dehydrogenase and ATP-regulated pathway in boar spermatozoa. Mol Reprod Dev (2006) 0.89
Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. Diabetes (2002) 0.88
Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop. Diabetes Res Clin Pract (2012) 0.88
Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue. Mol Cell Proteomics (2007) 0.87
Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: the di@bet.es study. Acta Diabetol (2013) 0.85
In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18. Eur J Immunol (2011) 0.85
Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle. J Pineal Res (2014) 0.85
Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus. Diabetes Res Clin Pract (2003) 0.84
Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation. Endocrinology (2005) 0.84
Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis. Diabetes (2013) 0.84
Characterization of the transcriptional activity of the basic helix-loop-helix (bHLH) transcription factor Atoh8. Biochim Biophys Acta (2013) 0.84
Targeting type 2 diabetes: lessons from a knockout model of insulin receptor substrate 2. Can J Physiol Pharmacol (2014) 0.84
Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis. Biochim Biophys Acta (2005) 0.84
The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway. J Biol Chem (2003) 0.84
Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study. Diabetes Care (2011) 0.83
BACE2 plays a role in the insulin receptor trafficking in pancreatic ß-cells. Am J Physiol Endocrinol Metab (2010) 0.83
In vivo JNK activation in pancreatic β-cells leads to glucose intolerance caused by insulin resistance in pancreas. Diabetes (2013) 0.83
Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach. BMC Genomics (2009) 0.83
Neuronal glycogen synthesis contributes to physiological aging. Aging Cell (2014) 0.83
Tungstate treatment improves Leydig cell function in streptozotocin-diabetic rats. J Androl (2005) 0.83
Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes. Obes Surg (2006) 0.83
Hepatic glycogen synthesis in the absence of glucokinase: the case of embryonic liver. J Biol Chem (2007) 0.82
Expression of TMEM16A and SLC4A4 in human pancreatic islets. Cell Physiol Biochem (2012) 0.82
The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study. Diabetes Technol Ther (2014) 0.82
Processivity and subcellular localization of glycogen synthase depend on a non-catalytic high affinity glycogen-binding site. J Biol Chem (2011) 0.82
Tungstate reduces the expression of gluconeogenic enzymes in STZ rats. PLoS One (2012) 0.81
Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur J Immunol (2003) 0.81
Subcellular localization of liver FBPase is modulated by metabolic conditions. FEBS Lett (2004) 0.81
Ambient temperature and prevalence of obesity in the Spanish population: The Di@bet.es study. Obesity (Silver Spring) (2014) 0.80
Sodium tungstate activates glycogen synthesis through a non-canonical mechanism involving G-proteins. FEBS Lett (2012) 0.80
Role of IGFBP-3 in the regulation of β-cell mass during obesity: adipose tissue/β-cell cross talk. Endocrinology (2011) 0.80
Sequence and epigenetic determinants in the regulation of the Math6 gene by Neurogenin3. Differentiation (2011) 0.80
Application of electrophoretic mobility shift assay and chromatin immunoprecipitation in the study of transcription in adipose cells. Methods Mol Biol (2008) 0.80
Lyase activity of glycogen synthase: Is an elimination/addition mechanism a possible reaction pathway for retaining glycosyltransferases? IUBMB Life (2012) 0.79
Impaired glucose tolerance: is there a case for pharmacologic intervention? Treat Endocrinol (2002) 0.79
Inhibition of GSK3 dependent tau phosphorylation by metals. Curr Alzheimer Res (2006) 0.79
Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation. J Neurosci Res (2006) 0.79
Sodium tungstate decreases sucrase and Na+/D-glucose cotransporter in the jejunum of diabetic rats. Am J Physiol Gastrointest Liver Physiol (2008) 0.79
Zonal distribution of glycogen synthesis in isolated rat hepatocytes. FEBS Lett (2002) 0.79
S 23521 decreases food intake and body weight gain in diet-induced obese rats. Obes Res (2004) 0.79
Amylin and hypertension: association of an amylin -G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats. J Clin Endocrinol Metab (2007) 0.79
Crystallization and preliminary X-ray analysis of the glycogen synthase from Pyrococcus abyssi. Acta Crystallogr D Biol Crystallogr (2003) 0.79
Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149. Biochem J (2004) 0.79
Adult-onset atypical (type 1) diabetes: additional insights and differences with type 1A diabetes in a European Mediterranean population. Diabetes Care (2004) 0.78
Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats. Proteomics (2005) 0.78
Histone demethylase KDM1A represses inflammatory gene expression in preadipocytes. Obesity (Silver Spring) (2013) 0.78
Muscle glycogen synthase isoform is responsible for testicular glycogen synthesis: glycogen overproduction induces apoptosis in male germ cells. J Cell Biochem (2013) 0.78
The presence of a high-Km hexokinase activity in dog, but not in boar, sperm. FEBS Lett (2004) 0.78
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats. Diabetes (2003) 0.78
Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat. Diabetologia (2013) 0.78